{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:50:20Z","timestamp":1790614220941,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.tips.2009.02.002","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T14:17:13Z","timestamp":1237817833000},"page":"228-233","source":"Crossref","is-referenced-by-count":51,"title":["Drug development and the cellular quality control system"],"prefix":"10.1016","volume":"30","author":[{"given":"P. Michael","family":"Conn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Ann","family":"Janovick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2009.02.002_bib1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0959-440X(00)00112-3","article-title":"Misfolding of membrane proteins in health and disease: the lady or the tiger?","volume":"10","author":"Sanders","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.tips.2009.02.002_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0955-0674(00)00233-7","article-title":"ER quality control: towards an understanding at the molecular level","volume":"13","author":"Ellgaard","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.tips.2009.02.002_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nature02262","article-title":"Quality control in the endoplasmic reticulum protein factory","volume":"426","author":"Sitia","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tips.2009.02.002_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1600-0854.2004.00232.x","article-title":"Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease","volume":"5","author":"Ulloa-Aguirre","year":"2004","journal-title":"Traffic"},{"key":"10.1016\/j.tips.2009.02.002_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(99)01445-0","article-title":"Protein misfolding, evolution and disease","volume":"24","author":"Dobson","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tips.2009.02.002_bib6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0197-4580(02)00076-3","article-title":"Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms","volume":"23","author":"Forloni","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tips.2009.02.002_bib7","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1038\/35041139","article-title":"Conformational disease","volume":"2","author":"Kopito","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tips.2009.02.002_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.tips.2009.02.002_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/cb600360h","article-title":"G-protein-coupled receptor trafficking: understanding the chemical basis of health and disease","volume":"1","author":"Ulloa-Aguirre","year":"2006","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tips.2009.02.002_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1210\/er.2004-0010","article-title":"Beyond the signal sequence: protein routing in health and disease","volume":"26","author":"Castro-Fernandez","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tips.2009.02.002_bib11","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1172\/JCI2303","article-title":"Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones","volume":"101","author":"Tamarappoo","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2009.02.002_bib12","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1073\/pnas.97.4.1796","article-title":"Chemical chaperones mediate increased secretion of mutant \u03b1 1-antitrypsin (\u03b1 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in \u03b1 1-AT deficiency","volume":"97","author":"Burrows","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2009.02.002_bib13","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1210\/jc.87.7.3255","article-title":"Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target","volume":"87","author":"Janovick","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2009.02.002_bib14","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1210\/jc.2002-020961","article-title":"Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism","volume":"87","author":"Leanos-Miranda","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2009.02.002_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/14728222.7.2.175","article-title":"Misrouted cell surface receptors as a novel disease aetiology and potential therapeutic target: the case of hypogonadotropic hypogonadism due to gonadotropin-releasing hormone resistance","volume":"7","author":"Ulloa-Aguirre","year":"2003","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.tips.2009.02.002_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/humupd\/dmh015","article-title":"Misrouted cell surface GnRH receptors as a disease aetiology for congenital isolated hypogonadotrophic hypogonadism","volume":"10","author":"Ulloa-Aguirre","year":"2004","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.tips.2009.02.002_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.coph.2004.08.001","article-title":"Pharmacological chaperone action on G-protein-coupled receptors","volume":"4","author":"Bernier","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tips.2009.02.002_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tem.2004.05.003","article-title":"Pharmacological chaperones: potential treatment for conformational diseases","volume":"15","author":"Bernier","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tips.2009.02.002_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbadis.2004.07.001","article-title":"Transgenic mouse expressing human mutant \u03b1-galactosidase A in an endogenous enzyme deficient background: a biochemical animal model for studying active-site specific chaperone therapy for Fabry disease","volume":"1690","author":"Ishii","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2009.02.002_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1511\/2005.54.967","article-title":"A new understanding of protein mutation unfolds","volume":"93","author":"Conn","year":"2005","journal-title":"Am. Sci."},{"key":"10.1016\/j.tips.2009.02.002_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10863-005-9499-3","article-title":"Rescue of folding defects in ABC transporters using pharmacological chaperones","volume":"37","author":"Loo","year":"2005","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.tips.2009.02.002_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1096\/fj.04-2375com","article-title":"A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder","volume":"19","author":"Yam","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2009.02.002_bib23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1517\/14728214.10.4.891","article-title":"Current and emerging therapies for the lysosomal storage disorders","volume":"10","author":"Pastores","year":"2005","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.tips.2009.02.002_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10545-006-0287-y","article-title":"\u03b2-Galactosidase deficiency: an approach to chaperone therapy","volume":"29","author":"Suzuki","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.tips.2009.02.002_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/mol.106.023994","article-title":"Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones","volume":"70","author":"Wang","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2009.02.002_bib26","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1242\/jcs.114.22.4073","article-title":"Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells","volume":"114","author":"Dormer","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tips.2009.02.002_bib27","doi-asserted-by":"crossref","first-page":"19723","DOI":"10.1074\/jbc.M101892200","article-title":"Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds","volume":"276","author":"Galietta","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2009.02.002_bib28","doi-asserted-by":"crossref","first-page":"51232","DOI":"10.1074\/jbc.M309076200","article-title":"Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator","volume":"278","author":"Zhang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2009.02.002_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10545-006-0251-x","article-title":"Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease","volume":"29","author":"Amaral","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.tips.2009.02.002_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.physiol.63.1.607","article-title":"Nephrogenic diabetes insipidus","volume":"63","author":"Morello","year":"2001","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.tips.2009.02.002_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2006.01.006","article-title":"Nephrogenic diabetes insipidus","volume":"13","author":"Bichet","year":"2006","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.tips.2009.02.002_bib32","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1074\/jbc.M312101200","article-title":"Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H","volume":"279","author":"Noorwez","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2009.02.002_bib33","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1093\/emboj\/cdf609","article-title":"Altered aggregation properties of mutant \u03b3-crystallins cause inherited cataract","volume":"21","author":"Sandilands","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.tips.2009.02.002_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1350-9462(98)00023-8","article-title":"Theoretical and experimental basis for the inhibition of cataract","volume":"18","author":"Benedek","year":"1999","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.tips.2009.02.002_bib35","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1172\/JCI34355","article-title":"Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria","volume":"118","author":"Pey","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2009.02.002_bib36","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1073\/pnas.110138997","article-title":"Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy","volume":"97","author":"Heiser","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2009.02.002_bib37","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1096\/fj.01-0841fje","article-title":"Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a \u03b2-sheet breaker peptide","volume":"16","author":"Permanne","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2009.02.002_bib38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(99)11419-3","article-title":"Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides","volume":"355","author":"Soto","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2009.02.002_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrn1587","article-title":"Modulation of neurodegeneration by molecular chaperones","volume":"6","author":"Muchowski","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2009.02.002_bib40","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1038\/sj.onc.1206777","article-title":"Rescue of mutant p53 transcription function by ellipticine","volume":"22","author":"Peng","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.tips.2009.02.002_bib41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/pr.59.3.2","article-title":"G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo","volume":"59","author":"Conn","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2009.02.002_bib42","doi-asserted-by":"crossref","first-page":"13727","DOI":"10.1074\/jbc.275.18.13727","article-title":"Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human \u03b4 opioid receptor","volume":"275","author":"Petaja-Repo","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2009.02.002_bib43","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1074\/jbc.M007151200","article-title":"Newly synthesized human \u03b4 opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome","volume":"276","author":"Petaja-Repo","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2009.02.002_bib44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.64.3.570","article-title":"Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail","volume":"64","author":"Andersson","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2009.02.002_bib45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1600-0854.2003.00097.x","article-title":"Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors","volume":"4","author":"Lu","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.tips.2009.02.002_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2121-5-34","article-title":"Endoplasmic reticulum degradation impedes olfactory G-protein coupled receptor functional expression","volume":"5","author":"Lu","year":"2004","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.tips.2009.02.002_bib47","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1210\/me.2003-0073","article-title":"Thyrotropin-releasing hormone receptor processing: role of ubiquitination and proteasomal degradation","volume":"17","author":"Cook","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tips.2009.02.002_bib48","doi-asserted-by":"crossref","first-page":"26622","DOI":"10.1074\/jbc.M413815200","article-title":"Inefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surface","volume":"280","author":"Pietila","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2009.02.002_bib49","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/jpet.102.048454","article-title":"Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor","volume":"305","author":"Janovick","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2009.02.002_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/joe.1.06771","article-title":"\u2019Effective inefficiency\u2019: cellular control of protein trafficking as a mechanism of post-translational regulation","volume":"190","author":"Conn","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tips.2009.02.002_bib51","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1210\/me.2006-0066","article-title":"Protein folding as posttranslational regulation: evolution of a mechanism for controlled plasma membrane expression of a G protein-coupled receptor","volume":"20","author":"Conn","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tips.2009.02.002_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-8674(00)80739-4","article-title":"From computer simulations to human disease: emerging themes in protein folding","volume":"97","author":"Radford","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.tips.2009.02.002_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1051\/jcp\/1968650044","article-title":"Are there pathways for protein folding?","volume":"65","author":"Levinthal","year":"1968","journal-title":"J. Chim. Phys."},{"key":"10.1016\/j.tips.2009.02.002_bib54","doi-asserted-by":"crossref","first-page":"24506","DOI":"10.1074\/jbc.M501978200","article-title":"Parallel regulation of membrane trafficking and dominant-negative effects by misrouted gonadotropin-releasing hormone receptor mutants","volume":"280","author":"Knollman","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2009.02.002_bib55","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1074\/jbc.M510601200","article-title":"Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy","volume":"281","author":"Janovick","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2009.02.002_bib56","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1210\/me.2004-0091","article-title":"Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect","volume":"18","author":"Brothers","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tips.2009.02.002_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/me.12.2.161","article-title":"Addition of catfish gonadotropin-releasing hormone (GnRH) receptor intracellular carboxyl-terminal tail to rat GnRH receptor alters receptor expression and regulation","volume":"12","author":"Lin","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tips.2009.02.002_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/me.2008-0384","article-title":"Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: the GnRH receptor","volume":"23","author":"Janovick","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tips.2009.02.002_bib59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/mi.2.5.308","article-title":"Protein origami: therapeutic rescue of misfolded gene products","volume":"2","author":"Conn","year":"2002","journal-title":"Mol. Interv."},{"key":"10.1016\/j.tips.2009.02.002_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mce.2008.10.051","article-title":"Trafficking and quality control of the gonadotropin releasing hormone receptor in health and disease","volume":"299","author":"Conn","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tips.2009.02.002_bib61","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2004-2071","article-title":"In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles","volume":"90","author":"Leanos-Miranda","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2009.02.002_bib62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mce.2008.09.015","article-title":"Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine","volume":"298","author":"Janovick","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tips.2009.02.002_bib63","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/emboj\/21.7.1628","article-title":"Ligands act as pharmacological chaperones and increase the efficiency of \u03b4 opioid receptor maturation","volume":"21","author":"Petaja-Repo","year":"2002","journal-title":"EMBO J."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614709000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614709000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T14:04:12Z","timestamp":1633269852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614709000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0165614709000376"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2009.02.002","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}